Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 79 articles: HTML format

Single Articles

June 2009
1. MOHRI Y , Mohri T, Wei W, Qi YJ, et al
   Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
   Br J Cancer. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. KIM Y , Shin A, Gwack J, Ko KP, et al
   Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study.
   Br J Cancer. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. IWATSUKI M , Fukagawa T, Mimori K, Nakanishi H, et al
   Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.
   Br J Cancer. 2009;100:1937-42.
   PubMed     Related articles    Abstract available
   
   
   
4. STARLING N , Okines A, Cunningham D, Allum W, et al
   A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.
   Br J Cancer. 2009;100:1725-30.
   PubMed     Related articles    Abstract available
   
   
   May 2009
5. DUAN L , Wu AH, Sullivan-Halley J, Bernstein L, et al
   Passive smoking and risk of oesophageal and gastric adenocarcinomas.
   Br J Cancer. 2009;100:1483-5.
   PubMed     Related articles    Abstract available
   
   
   April 2009
6. BOEGL M , Prinz C
   CD133 expression in different stages of gastric adenocarcinoma.
   Br J Cancer. 2009;100:1365-6.
   PubMed     Related articles   
   
   
   
7. POULSEN AH , Christensen S, McLaughlin JK, Thomsen RW, et al
   Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
   Br J Cancer. 2009.
   PubMed     Related articles    Abstract available
   
   
   March 2009
8. HIRATA Y , Ogasawara N, Sasaki M, Mizushima T, et al
   BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.
   Br J Cancer. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. KIM JS , Kim MA, Kim TM, Lee SH, et al
   Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
   Br J Cancer. 2009;100:732-8.
   PubMed     Related articles    Abstract available
   
   
   February 2009
10. MURAYAMA T , Inokuchi M, Takagi Y, Yamada H, et al
    Relation between outcomes and localisation of p-mTOR expression in gastric cancer.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. ROHWER N , Lobitz S, Daskalow K, Jons T, et al
    HIF-1alpha determines the metastatic potential of gastric cancer cells.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    
12. BERTUCCIO P , Praud D, Chatenoud L, Lucenteforte E, et al
    Dietary glycemic load and gastric cancer risk in Italy.
    Br J Cancer. 2009;100:558-61.
    PubMed     Related articles    Abstract available
    
    
    
13. ABNET CC , Freedman ND, Kamangar F, Leitzmann MF, et al
    Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
    Br J Cancer. 2009;100:551-7.
    PubMed     Related articles    Abstract available
    
    
    January 2009
14. BARROS-SILVA JD , Leitao D, Afonso L, Vieira J, et al
    Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. YING J , Poon FF, Yu J, Geng H, et al
    DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. ANDERS M , Vieth M, Rocken C, Ebert M, et al
    Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. DEANS DA , Tan BH, Wigmore SJ, Ross JA, et al
    The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.
    Br J Cancer. 2009;100:63-9.
    PubMed     Related articles    Abstract available
    
    
    
18. VERSCHUUR EM , Steyerberg EW, Tilanus HW, Polinder S, et al
    Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.
    Br J Cancer. 2009;100:70-6.
    PubMed     Related articles    Abstract available
    
    
    
19. HAN SW , Oh DY, Im SA, Park SR, et al
    Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
20. OHTA H , Aoyagi K, Fukaya M, Danjoh I, et al
    Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    
21. KITA Y , Fukagawa T, Mimori K, Kosaka Y, et al
    Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    November 2008
22. BUFFART TE , Overmeer RM, Steenbergen RD, Tijssen M, et al
    MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    
23. CATALANO V , Graziano F, Santini D, D'Emidio S, et al
    Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    Br J Cancer. 2008;99:1402-7.
    PubMed     Related articles    Abstract available
    
    
    
24. CHENG YY , Jin H, Liu X, Siu JM, et al
    Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    October 2008
25. LEE HE , Chae SW, Lee YJ, Kim MA, et al
    Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    September 2008
26. MURRAY D , Horgan G, Macmathuna P, Doran P, et al
    NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    
27. TAKENO A , Takemasa I, Doki Y, Yamasaki M, et al
    Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    
28. RAO S , Cunningham D
    Survival from cancer of the stomach in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S19-20.
    PubMed     Related articles   
    
    
    
29. MITRY E , Rachet B, Quinn MJ, Cooper N, et al
    Survival from cancer of the stomach in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S16-8.
    PubMed     Related articles   
    
    
    
30. SENAPATI S , Chaturvedi P, Sharma P, Venkatraman G, et al
    Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
    Br J Cancer. 2008;99:949-56.
    PubMed     Related articles    Abstract available
    
    
    
31. SCHONNEMANN KR , Jensen HA, Yilmaz M, Jensen BY, et al
    Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.
    Br J Cancer. 2008;99:858-61.
    PubMed     Related articles    Abstract available
    
    
    
32. RAO S , Starling N, Cunningham D, Benson M, et al
    Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer.
    Br J Cancer. 2008;99:868-74.
    PubMed     Related articles    Abstract available
    
    
    August 2008
33. SCHONNEMANN KR , Jensen HA, Yilmaz M, Jensen BV, et al
    Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    July 2008
34. LEE JL , Kang YK, Kang HJ, Lee KH, et al
    A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    Br J Cancer. 2008.
    PubMed     Related articles    Abstract available
    
    
    
35. SUZUKI S , Sasajima K, Sato Y, Watanabe H, et al
    MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer.
    Br J Cancer. 2008;99:350-6.
    PubMed     Related articles    Abstract available
    
    
    June 2008
36. SMITH LM , Nesterova A, Ryan MC, Duniho S, et al
    CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
37. CASTELL F , Cook GJ
    Quantitative techniques in 18FDG PET scanning in oncology.
    Br J Cancer. 2008;98:1597-601.
    PubMed     Related articles    Abstract available
    
    
    
38. KIM MS , Jeong EG, Yoo NJ, Lee SH, et al
    Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    Br J Cancer. 2008;98:1533-5.
    PubMed     Related articles    Abstract available
    
    
    April 2008
39. BAHMANYAR S , Lambe M, Zendehdel K, Nyren O, et al
    Parity and risk of stomach cancer by sub-site: a national Swedish study.
    Br J Cancer. 2008;98:1295-300.
    PubMed     Related articles    Abstract available
    
    
    March 2008
40. PARK SR , Kim HK, Kim CG, Choi IJ, et al
    Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. WEI J , Zou Z, Qian X, Ding Y, et al
    ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. KUBOTA T
    The role of S-1 in the treatment of gastric cancer.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. MCKERNAN M , McMillan DC, Anderson JR, Angerson WJ, et al
    The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.
    Br J Cancer. 2008;98:888-93.
    PubMed     Related articles    Abstract available
    
    
    
44. GOROUHI F , Islami F, Bahrami H, Kamangar F, et al
    Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
45. LEE MK , Lee KM, Bae JM, Kim S, et al
    Employment status and work-related difficulties in stomach cancer survivors compared with the general population.
    Br J Cancer. 2008;98:708-15.
    PubMed     Related articles    Abstract available
    
    
    
46. GRIFFITHS EA , Pritchard SA, McGrath SM, Valentine HR, et al
    Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. OTSUBO T , Akiyama Y, Yanagihara K, Yuasa Y, et al
    SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
48. KANG HJ , Chang HM, Kim TW, Ryu MH, et al
    A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.
    Br J Cancer. 2008;98:316-22.
    PubMed     Related articles    Abstract available
    
    
    
49. MATSUBARA J , Nishina T, Yamada Y, Moriwaki T, et al
    Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. KIM JG , Sohn SK, Chae YS, Song HS, et al
    Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. WU CW , Chiou JM, Ko FS, Lo SS, et al
    Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial.
    Br J Cancer. 2008;98:54-9.
    PubMed     Related articles    Abstract available
    
    
    
52. KATSURAGI K , Yashiro M, Hirakawa K
    Reply: Identification of isolated tumour cells by detection of CEA and CK mRNA in peritoneal lavage fluid of gastric cancer patients.
    Br J Cancer. 2008;.
    PubMed     Related articles   
    
    
    
53. DEANS DA , Wigmore SJ, Gilmour H, Tisdale MJ, et al
    Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.
    Br J Cancer. 2008;98:243.
    PubMed     Related articles   
    
    
    December 2007
54. MIZUKAMI Y , Kono K, Kawaguchi Y, Akaike H, et al
    Localisation pattern of Foxp3(+) regulatory T cells is associated with clinical behaviour in gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. SHODA H , Kakugawa Y, Saito D, Kozu T, et al
    Evaluation of (18)F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
    Br J Cancer. 2007;97:1493-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
56. KOSHIOL J , Qiao YL, Mark SD, Dawsey SM, et al
    Epstein-Barr virus serology and gastric cancer incidence and survival.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
57. ROSERO-BIXBY L , Sierra R
    X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica.
    Br J Cancer. 2007;97:837-43.
    PubMed     Related articles    Abstract available
    
    
    
58. VAN VLIET EP , Steyerberg EW, Eijkemans MJ, Kuipers EJ, et al
    Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis.
    Br J Cancer. 2007;97:868-76.
    PubMed     Related articles    Abstract available
    
    
    
59. SUTTIE SA , Park KG, Smith TA
    [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
    Br J Cancer. 2007;97:902-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
60. TAKAYAMA T , Sato Y, Sagawa T, Okamoto T, et al
    Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. CHENG YY , Yu J, Wong YP, Man EP, et al
    Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. JANSEN EP , Boot H, Dubbelman R, Bartelink H, et al
    Postoperative chemoradiotherapy in gastric cancer - a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
    Br J Cancer. 2007;97:712-6.
    PubMed     Related articles    Abstract available
    
    
    
63. DI LAURO L , Nunziata C, Arena MG, Foggi P, et al
    Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2007;97:593-7.
    PubMed     Related articles    Abstract available
    
    
    August 2007
64. KOLODZIEJCZYK P , Pituch-Noworolska A, Drabik G, Kulig J, et al
    The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
65. KATSURAGI K , Yashiro M, Sawada T, Osaka H, et al
    Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. JEUNG HC , Rha SY, Shin SJ, Ahn JB, et al
    A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. NAKAMURA Y , Tanaka F, Haraguchi N, Mimori K, et al
    Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. HAWINKELS LJ , Verspaget HW, van Duijn W, van der Zon JM, et al
    Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. SUNG NY , Choi KS, Park EC, Park K, et al
    Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. CHEN CC , Chen LT, Tsou TC, Pan WY, et al
    Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
71. YAMANAKA T , Matsumoto S, Teramukai S, Ishiwata R, et al
    Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. CHEN W , Dawsey SM, Qiao YL, Mark SD, et al
    Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. VAN BLANKENSTEIN M , Looman CW, Siersema PD, Kuipers EJ, et al
    Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003.
    Br J Cancer. 2007;96:1767-71.
    PubMed     Related articles    Abstract available
    
    
    May 2007
74. EL-ZAATARI M , Tobias A, Grabowska AM, Kumari R, et al
    De-regulation of the sonic hedgehog pathway in the InsGas mouse model of gastric carcinogenesis.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. KOSAKA Y , Mimori K, Fukagawa T, Ishikawa K, et al
    Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. VAN MEERTEN E , Eskens FA, van Gameren EC, Doorn L, et al
    First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.
    Br J Cancer. 2007;96:1348-52.
    PubMed     Related articles    Abstract available
    
    
    
77. OH SC , Sur HY, Sung HJ, Choi IK, et al
    A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
78. KIM JS , Chung SJ, Choi YS, Cheon JH, et al
    Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
79. TAJIMA Y , Yamazaki K, Makino R, Nishino N, et al
    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
    Br J Cancer. 2007;96:631-8.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: